The effects of menopausal status and disease activity on biochemical markers of bone metabolism in female patients with rheumatoid arthritis

British Journal of Rheumatology

Volumn 37, Issue 6, 1998, Pages 653-658

  Suzuki, M ^a   Takahashi, M ^a   Miyamoto, S ^a   Hoshino, H ^a   Kushida, K ^a   Miura, M ^b   Inoue, T ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b LSI MEDIENCE CORPORATION   (Japan)

Author keywords

Bone formation markers; Bone metabolism; Bone resorption markers; Disease activity; Menopause; Rheumatoid arthritis

Indexed keywords

ALKALINE PHOSPHATASE; BIOCHEMICAL MARKER; DEOXYPYRIDINOLINE; OSTEOCALCIN; PYRIDINOLINE;

ADULT; AGED; ARTICLE; BONE METABOLISM; BONE TURNOVER; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MENOPAUSE; OSSIFICATION; OSTEOLYSIS; OSTEOPENIA; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; URINE LEVEL;

EID: 0031901222     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/37.6.653     Document Type: Article

References (46)

1. Kenedy AC, Lindsay R. Bone involvement in rheumatoid arthritis. Clin Rheum Dis 1977;3:403-20.
2. Åkesson K, Önsten I, Obrant KJ. Periarticular bone in rheumatoid arthritis versus arthrosis. Acta Orthop Scand 1994;65:135-8.
3. Kröger H, Arnala I, Rehnberg V, Hämäläinen M, Alhava E. Histomorphometry of periarticular bone in rheumatoid arthritis. Ann Chir Gynaecol 1994;83:56-62.
4. Compston JE, Vedi S, Mellish RWE, Croucher P, O'Sullivan MM. Reduced bone formation in non-steroid treated patients with rheumatoid arthritis. Ann Rheum Dis 1989;48:483-7.
5. Shimizu S, Shiozawa S, Shiozawa K, Imura S, Fujita T. Quantitative histologic studies on the pathogenesis of periarticular osteoporosis in rheumatoid arthritis. Arthritis Rheum 1985;28:25-31.
6. Gough AKS, Lilley J, Eyre S, Holder RL, Emery P. Generalized bone loss in patients with early rheumatoid arthritis. Lancet 1994;344:23-7.
7. Van Soesbergen RM, Lips P, Van den Ende A, Van der Korst JK. Bone metabolism in rheumatoid arthritis compared with postmenopausal osteoporosis. Ann Rheum Dis 1986;45:149-55.
8. Rico H, Hernandez ER, Gomez-Castresana, Yague M, Cabranes JA, Valor R. Osteopenia in rheumatoid arthritis: a biochemical, hormonal and histomorphometric study. Clin Rheumatol 1990;9:63-8.
9. Lane NE, Pressman AR, Star VL, Cummings SR, Nevitt MC. The study of osteoporotic fractures research group. Rheumatoid arthritis and bone mineral density in elderly women. J Bone Miner Res 1995;10:257-63.
10. Peretz A, Praet JP, Rozenberg S, Bosson D, Famaey JP, Bourdoux P. Osteocalcin and bone mineral content in rheumatoid arthritis. Clin Rheumatol 1989;8:42-8.
11. Toyoda T, Inokuchi S, Saito S, Horie Y, Tomita S. Bone loss of the radius in rheumatoid arthritis. Acta Orthop Scand 1996;67:269-73.
12. Laan RFJM, Buijs WCAM, Verbeek ALM, Draad MP, Corstens FHM, van de Putte LBA et al. Bone mineral density in patients with recent onset rheumatoid arthritis: influence of disease activity and functional capacity. Ann Rheum Dis 1993;52:21-6.
13. Gough AKS, Peel NFA, Eastell R, Holder RL, Lilley J, Emery P. Excretion of pyridinium crosslinks correlates with disease activity and appendicular bone loss in early rheumatoid arthritis. Ann Rheum Dis 1994;53:14-7.
14. Weisman MH, Orth RW, Catherwood BD, Manolagas SC, Deftos LJ. Measures of bone loss in rheumatoid arthritis. Arch Intern Med 1986;146:701-4.
15. Sambrook PN, Ansell BM, Foster S, Gumpel JM, Hesp R, Reeve J et al. Bone turnover in early rheumatoid arthritis. 1. Biochemical and kinetic indexes. Ann Rheum Dis 1985;44:575-9.
16. Marhoffer W, Schatz H, Stracke H, Ullmann J, Schmidt K, Federlin K. Serum osteocalcin levels in rheumatoid arthritis: A marker for accelerated bone turnover in late onset rheumatoid arthritis. J Rheumatol 1991;18:1158-62.
17. Rico H, Revilla M, Alvarez de Buergo M, Villa LF. Serum osteocalcin and calcitropic hormones in a homogeneous group of patients with rheumatoid arthritis: its implication in the osteopenia of the disease. Clin Exp Rheumatol 1993;11:53-6.
18. Eggelmeijer F, Papapoulos SE, Westedt ML, van Paassen HC, Dijkmans BAC, Breedveld FC. Bone metabolism in rheumatoid arthritis; Relation to disease activity. Br J Rheumatol 1993;32:387-91.
19. Als OS, Riis BJ, Gotfredsen A, Christiansen C, Deftos LJ. Biochemical markers of bone turnover in rheumatoid arthritis. Relation to anti-inflammatory treatment, sex, and menopause. Acta Med Scand 1986;219:209-13.
20. Hauschka PV, Lian JB, Gallop PM. Vitamin K and mineralization. Trends Biochem Sci 1978;3:75-8.
21. Garnero P, Delmas PD. Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease. J Clin Endocrinol Metab 1993;77:1046-53.
22. van Straalen JP, Sanders E, Prummel MF, Sanders GTB. Bone-alkaline phosphatase as indicator of bone formation. Clin Chim Acta 1991;201:27-34.
23. Eyre DR, Koob TJ, van Ness KP. Quantitation of hydroxypyridinium crosslinks in collagen by high-performance liquid chromatography. Anal Biochem 1984;137:380-8.
24. Black D, Duncan A, Robins SP. Quantitative analysis of the pyridinium crosslinks of collagen in urine using ion-paired reversed-phase high-performance liquid chromatography. Anal Biochem 1988;169:197-203.
25. Takahashi M, Hoshino H, Kushida K, Inoue T. Direct measurement of crosslinks, pyridinoline, deoxypyridinoline, and pentosidine, in the hydrolysate of tissue using high-performance liquid chromatography. Anal Biochem 1995;232:158-62.
26. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
27. Pratt DA, Daniloff Y, Duncan A, Robins SP. Automated analysis of the pyridinium crosslinks of collagen in tissue and urine using solid-phase extraction and reversed-phase high performance liquid chromatography. Anal Biochem 1992;207:168-75.
28. Lansbury J. Numerical method of evaluating the status of rheumatoid arthritis. Ann Rheum Dis 1957;16:101-7.
29. Ekenstam EA, Ljunghall S, Hällgren R. Serum osteocalcin in rheumatoid arthritis and other inflammatory arthritides: relation between inflammatory activity and the effect of glucocorticoids and remission inducing drugs. Ann Rheum Dis 1986;45:484-90.
30. Campion GV, Delmas PD, Dieppe PA. Serum and synovial fluid osteocalcin (Bone gla protein) levels in joint disease. J Rheumatol 1989;28:393-8.
31. Kröger H, Risteli J, Risteli L, Penttilä I, Alhava E. Serum osteocalcin and carboxyterminal propeptide of type I procollagen in rheumatoid arthritis. Ann Rheum Dis 1993;52:338-42.
32. Pietschmann P, Machold KP, Wolosczuk W, Smolen JS. Serum osteocalcin concentrations in patients with rheumatoid arthritis. Ann Rheum Dis 1989;48:654-7.
33. Franck H, Ittel TH, Tasch O, Herborn G, Rau R. Osteocalcin in patients with rheumatoid arthritis - effect of anatomical stages, inflammatory activity and therapy. Rheumatol Int 1992;12:207-11.
34. Gevers G, Devos P, De Roo M, Dequeker J. Increased levels of osteocalcin (serum bone gla-protein) in rheumatoid arthritis. Br J Rheumatol 1986;25:260-2.
35. Garnero P, Gineyts E, Arbault P, Christiansen C, Delmas PD. Different effects of bisphosphonate and estrogen therapy on free and peptide-bound bone cross-links excretion. J Bone Miner Res 1995;10:641-9.
36. Randall AG, Kent GN, Garcia-Webb P, Bhagat CI, Pearce DJ, Gutteridge DH et al. Comparison of biochemical markers of bone turnover in Paget disease treated with pamidronate and a proposed model for the relationships between measurements of the different forms of pyridinoline cross-links. J Bone Miner Res 1996; 11:1176-84.
37. Black D, Marabani M, Sturrock RD, Robins SP. Urinary excretion of the hydroxypyridinium cross links of collagen in patients with rheumatoid arthritis. Ann Rheum Dis 1989;48:641-4.
38. Robins SP, Stewart P, Astbury C, Bird HA. Measurement of the cross linking compound, pyridinoline, in urine as an index of collagen degradation in joint disease. Ann Rheum Dis 1986;45:969-73.
39. Seibel MJ, Duncan A, Robins SP. Urinary hydroxypyridinium crosslinks provide indices of cartilage and bone involvement in arthritic diseases. J Rheumatol 1989;16:964-70.
40. Eyre DR. Collagen cross-linking amino acids. Methods Enzymol 1987;144:115-39.
41. Hall GM, Spector TD, Delmas PD. Markers of bone metabolism in postmenopausal women with rheumatoid arthritis. Arthritis Rheum 1995;38:902-6.
42. Spector TD, James IT, Hall GM, Thompson PW, Perrett D, Hart DJ. Increased levels of urinary collagen crosslinks in females with rheumatoid arthritis. Clin Rheumatol 1993;12:240-4.
43. Astbury C, Bird HA, McLaren AM, Robins SP. Urinary excretion of pyridinium crosslinks of collagen correlated with joint damage in arthritis. Br J Rheumatol 1994;33:11-5.
44. Verstraeten A, Dequeker J. Vertebral and peripheral bone mineral content and fracture incidence in postmenopausal patients with rheumatoid arthritis: effect of low dose corticosteroids. Ann Rheum Dis 1986;45:852-7.
45. Leboff MS, Wade JP, Mackowiak S, Fuleihan GEH, Zangari M, Liang MH. Low dose prednisone does not affect calcium homeostasis or bone density in postmenopausal women with rheumatoid arthritis. J Rheumatol 1991;18:339-44.
46. Sambrook PN, Cohen ML, Eisman JA, Pocock NA, Champion GD, Yeates MG. Effects of low dose corticosteroids on bone mass in rheumatoid arthritis: a longitudinal study. Ann Rheum Dis 1989;48:535-8.